Recalls / Active ingredient / Clonidine
Clonidine
2 FDA drug recalls involving the active ingredient “Clonidine”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2022-06-09 | Class II | Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only | Mayne Pharma Inc |
| 2021-10-28 | Class III | Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laborato | Teva Pharmaceuticals USA |